Jim Simons acquired 582 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $53.8 Million. That's 0.09% of their equity portfolio (250th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q4 2013. Since then Jim Simons bought shares fifteen more times and sold shares on seventeen occasions. The stake costed the investor $49 Million, netting the investor a gain of 9.8% so far.